Table 2.
Clinical, cancer-related characteristics of propensity-matched samples (n = 828) in the LIVESTRONG dataset
| Characteristic | LGBT, n = 207 | Matched heterosexual n = 621 | p |
|---|---|---|---|
| Common cancers, n (%) | |||
| Breast | 42 (20.3) | 142 (22.9) | >.05 |
| Testicular | 19 (9.2) | 50 (8.1) | >.05 |
| Prostate | 15 (7.2) | 52 (8.4) | >.05 |
| Colorectal | 15 (7.2) | 46 (7.4) | >.05 |
| Type of treatment, n (%) | |||
| Chemotherapy | 137 (66.2) | 406 (65.4) | >.05 |
| Radiation | 83 (40.1) | 259 (41.7) | >.05 |
| Surgery | 143 (69.1) | 452 (72.8) | >.05 |
| Hormone therapy | 37 (17.9) | 113 (18.2) | >.05 |
| Age at diagnosis | |||
| Mean (SE) | 41.94 (13.99) | 43.35 (21.24) | >.05 |
| Survivorship time, n (%) | |||
| Currently on treatment | 44 (21.3) | 128 (20.6) | >.05 |
| Less than 1 year | 27 (13.0) | 85 (13.7) | >.05 |
| 1 to 5 years | 68 (32.9) | 208 (33.5) | >.05 |
| More than 5 years | 45 (21.7) | 130 (20.9) | >.05 |
| Other/unknown | 23 (11.1) | 70 (11.3) | >.05 |